Residency · Rochester, NY
Sponsored by University of Rochester Medicine
Polycystic ovary syndrome.
Nature reviews. Disease primers · 2024 · 363 citations · Kathleen Hoeger
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
The New England journal of medicine · 2023 · 633 citations · Richard Moore
AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial.
Nature medicine · 2025 · 143 citations · Emma Ciafaloni
Update on PCOS: Consequences, Challenges, and Guiding Treatment.
The Journal of clinical endocrinology and metabolism · 2021 · 393 citations · Kathleen Hoeger
Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.
The Lancet. Oncology · 2023 · 172 citations · Warner Huh
Placental pathology is necessary to understand common pregnancy complications and achieve an improved taxonomy of obstetrical disease.
American journal of obstetrics and gynecology · 2023 · 111 citations · Judette Louis
Does race or ethnicity play a role in the origin, pathophysiology, and outcomes of preeclampsia? An expert review of the literature.
American journal of obstetrics and gynecology · 2022 · 175 citations · Judette Louis
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
Annals of oncology : official journal of the European Society for Medical Oncology · 2024 · 148 citations · Richard Moore